Randomized, placebo-controlled pilot trial of the effects of α-tocopherol supplementation on levels of autoantibodies against 5-hydroxymethyl-2-deoxyuridine in melanoma patients

Melanoma Research

Volumn 14, Issue 1, 2004, Pages 49-56

  Mahabir, Somdat ^a   Frenkel, Krystyna ^c   Brady, Mary Sue ^c   Coit, Daniel ^b   Leibes, Leonard ^c   Karkoszka, Jerzy ^c   Berwick, Marianne ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

5 hydroxymethyl 2 deoxyuridine; Anti HMdU antibodies; Supplementation; Vitamin E; tocopherol

Indexed keywords

5 HYDROXYMETHYLDEOXYURIDINE; ALPHA TOCOPHEROL; AUTOANTIBODY; DNA; PLACEBO;

ADULT; ANTIBODY DETECTION; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA DAMAGE; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MELANOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

EID: 1642289525     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200402000-00008     Document Type: Article

References (48)

1. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66:1191-1308.
2. Harvard Report on Cancer Prevention. Causes of human cancer. Cancer Causes Control 1996; 7 (suppl):1-59.
3. Ames B, Wakimoto P. Are vitamin and mineral deficiencies a major cancer risk? Nat Rev Cancer 2002; 2:694-704.
4. Ames B. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 2001; 475:7-20.
5. Steinmetz K, Potter J. Vegetables, fruits, and cancer II. Mechanisms. Cancer Causes Control 1991; 2:427-442.
6. Blount B, Mack M, Wehr C, MacGregor T, Hiatt R, Wang G, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997; 94:3290-3295.
7. Hu JJ, Chi CX, Frenkel K, Smith BN, Henfelt JJ, Berwick M, et al. Alpha-tocopherol dietary supplement decreases titers of antibody against 5-hydroxymethyl-2′-deoxyuridine (HMdU). Cancer Epidemiol Biomarkers Prev 1999; 8 (8):693-698.
8. Pincheira J, Navarrete M, de la Torre C, Tapia G, Santos M. Effects of vitamin E on chromosomal aberrations in lymphocytes from patients with Down's syndrome. Clin Genet 1999; 55:192-197.
9. Factor V, Laskowska D, Jensen M, Woitach J, Popescu N, Thorgeirsson S. Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model. Proc Natl Acad Sci USA 2000; 97:2196-2201.
10. Antunes L, Takahashi C. Effects of high doses of vitamins C and E against doxorubicin-induced chromosomal damage in Wistar rat bone marrow cells. Mutat Res 1998; 419:137-143.
11. Mahabir S, Coit D, Liebes L, Brady MS, Lewis JJ, Roush G, et al. Randomized, placebo-controlled trial of dietary supplementation of alpha-tocopherol on mutagen sensitivity levels in melanoma patients: a pilot trial. Melanoma Res 2002; 12 (1):83-90.
12. Goodman M, Hernandez B, Wilkens L, Lee J, Marchand L, Liu L, et al. Effects of beta-carotene and alpha-tocopherol on bleomycin induced chromosomal damage. Cancer Epidemiol Biomarkers Prev 1998; 7: 113-117.
13. Fenech M, Dreosti I, Aitken C. Vitamin E supplements and their effect on vitamin E status in blood and genetic damage rate in peripheral blood lymphocytes. Carcinogenesis 1997; 18:359-364.
14. Frenkel K, Khasak D, Karkoszka J, Shupack J, Stiller M. Enhanced antibody titers to an oxidized DNA base in inflammatory and neoplastic diseases. Exp Dermatol 1992; 1:242-247.
15. Frenkel K, Karkoszka J, Kim E, Taioli E. Recognition of oxidized DNA bases by sera of patients with inflammatory diseases. Free Radic Biol Med 1993; 14:483-494.
16. Frenkel K, Karkoszka J, Glassman T, Dubin N, Toniolo P, Taioli E, et al. Serum autoantibodies recognizing 5-hydroxymethyl-2-deoxyuridine, an oxidized DNA base, as biomarker of cancer risk in women. Cancer Epidemiol Biomarkers Prev 1998; 7:49-57.
17. Halpern A, Altman J. Genetic predisposition to skin cancer. Curr Opin Oncol 1999; 11:132-138.
18. Gilchrest B, Eller M, Geller A, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. New Engl J Med 1999; 340:1341-1347.
19. Gilchrest B, Eller M. DNA photodamage stimulates melanogenesis and other photoprotective responses. J Investig Dermatol Symp Proc 1999; 4:35-40.
20. Block G, Hartman A, Dresser C, Carroll M, Gannon J, Gardner L. A database approach to diet questionnaire design and testing. Am J Epidemiol 1986; 124:453-469.
21. Hatam L, Kayden H. A high-performance liquid chromatographic method for determination of tocopherol in plasma and cellular elements of blood. J Lipid Res 1979; 20:639-645.
22. Kirkpatrick C, White E, Lee J. Case-control study of malignant melanoma in Washington state. II. Diet, alcohol, and obesity. Am J Epidemiol 1994; 139:869-880.
23. Bain C, Green A, Siskind V, Alexander J, Harvey P. Diet and melanoma. An exploratory case-control study. Ann Epidemiol 1993; 3:235-238.
24. Stryker W, Willett W. Diet, plasma levels of beta-carotene and alpha-tocopherol, and risk of malignant melanoma. Am J Epidemiol 1990; 131:597-611.
25. Breslow R, Albert A, Helzsouer K, Bush T, Norkus E, Morris J, et al. Serological precursors of cancer: malignant melanoma, basal and squamous cell skin cancer, and prediagnostic levels of retinol, beta-carotene, lycopene, alpha-tocopherol, and selenium. Cancer Epidemiol Biomarkers Prev 1995; 4:837-842.
26. Knekt P, Aromaa A, Maatela J, Alfthan G, Aran R, Nikari T, et al. Serum alpha-tocopherol, beta-carotene, retinol, retinol-binding protein and selenium and risk of cancers of low incidence in Finland. Am J Epidemiol 1991; 143:356-361.
27. Comstock G, Helzsouer K, Bush T. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. Am J Clin Nutr 1991; 53:260s-264s.
28. McDavid K, Breslow R, Radimer K. Vitamin/mineral supplementation among cancer survivors: 1987 and 1992 National Health Interview Surveys. Nutr Cancer 2001; 41:29-32.
29. Pinnell S. Cutaneous photodamage, oxidative stress, and topical antioxidant protection. J Am Acad Dermatol 2003; 48:1-19.
30. Dutie S, Ma A, Ross M, Collins A. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res 1996; 56:1291-1295.
31. Welch R, Turley E, Sweetman S, Kennedy G, Collins A, Dunne A, et al. Dietary antioxidant supplementation and DNA damage in smokers and nonsmokers. Nutr Cancer 1999; 34:167-172.
32. Baker H, Handelman G, Short S, Machlin L, Bhagvan H, Dratz E, et al. Comparison of plasma alpha and gamma-tocopherol levels following chronic oral administration of either all-rac-alpha-tocopheryl acetate or RRR-alpha-tocopheryl acetate in normal adult male subjects. Am J Clin Nutr 1986; 43:382-387.
33. Handelman G, Machlin L, Fitch K, Weiter J, Dratz E. Oral alpha-tocopherol supplements decrease plasma gamma-tocopherol levels in humans. J Nutr 1985; 115:807-813.
34. Behrens W, Madere R. Alpha- and gamma-tocopherol concentrations in human serum. J Am Coll Nutr 1986; 5:91-96.
35. Qin J, Berwick M, Ashbolt R, Dwyer T. Quantifying the change of melanoma incidence by Breslow thickness. Biometrics 2002; 58:665-670.
36. Owen S, Sanders L, Edwards L, Seigler H, Tyler D, Grichnik J. Identification of higher risk thin melanomas should be based on Breslow depth not dark level IV. Cancer 2001; 91:883-891.
37. Feskanich D, Hunter D, Willett W, Spiegelman D, Stampfer M, Speizer F, et al. Oral contraceptive use and risk of melanoma in premenopausal women. Br J Cancer 1999; 81:918-923.
38. Lavigne J, Goodman J, Fonong T, Odwin S, He P, Roberts D, et al. The effects of catechol-O-methytransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells. Cancer Res 2001; 61:7488-7494.
39. Cavalieri E, Kumar S, Todorovic R, Higginbotham S, Badawi A, Rogan E. Imbalance of estrogen homeostasis in kidney and liver of hamsters treated with estradiol: implications for estrogen-induced initiation of renal tumors. Chem Res Toxicol 2001; 4: 1041-1050.
40. Cavalieri E, Frenkel K, Liehr J, Rogan E, Roy D. Estrogens as endogenous genotoxic agents - DNA adducts and mutations. J Natl Cancer Inst Monogr 2000; 27:75-94.
41. Moszczynski P, Zabinski Z, Moszczynski PJ, Rutowski J, Slowinski S, Tabarowski Z. Immunological findings in cigarette smokers. Toxicol Lett 2001; 118:121-127.
42. Lei Y, Hwang S, Chang C, Kuo H, Luo J, Chang M, et al. Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. Mutat Res 2002; 519:93-101.
43. Mooney L, Perera F, Bennekum A, Blaner W, Karkoszka J, Covey L, et al. Gender differences in autoantibodies to oxidative DNA base damage in cigarette smokers. Cancer Epidemiol Biomarkers Prev 2001; 10:641-648.
44. Cooney R, Maskarinec G, Franke A, Okinaka L, Karkoszka J, Wilkens L, et al. Association of tocopherols with circulating autoantibody levels against an oxidized DNA nucleoside in humans. Free Radical Biol Med 2001; 31:460-468.
45. Beers M, Berkow R (editors). The Merck Manual. 17th edition. Rahway: Merck Research Laboratories; 1999.
46. Jiang Q, Christen S, Shigenaga M, Ames B. γ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 2001; 74:714-722.
47. McLaughlin P, Weihrauch J. Vitamin E content of foods. J Am Diet Assoc 1979; 75:647-665.
48. Jiang Q, Elson-Schwab I, Courtemanche C, Ames B. γ-Tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci USA 2002; 97:11494-11499.